Intra-operative haemodilution and autotransfusion was carried out in 32 patients having major vascular surgery. The intra-operative blood loss and peri-operative blood replacement was compared with that in 25 patients having similar surgery in whom haemodilution was considered to be contraindicated. Both groups of patients had similar mean intra-operative blood loss measured but homologous blood transfusion requirements were significantly different; 2.6 units (SD 1.9) in the haemodiluted patients compared with 6.0 units (SD 3.5) in the non-diluted patients. There was no mortality in the haemodiluted patients nor was any morbidity attributed to the procedure. Polygeline (haemaccel) was used as the diluent and proved satisfactory for this purpose.
This procedure probably represents the safest and most widely applicable method of haemodilution and autotransfusion but has a number of logistical problems which make it difficult to implement. Intra-operative haemodilution and autotransfusion is a procedure carried out at the time of surgery, which does not have these logistical problems and has the added advantage that fresh autologous blood is available for retransfusion. This fresh autologous blood contains red cells which do not have any storage lesion and has platelets and coagulation factors which may be of value if the patient requires a large transfusion of homologous blood.
The aims of this clinical study of intraoperative haemodilution and autotransfusion in patients having major vascular surgery were to determine the amount of homologous blood transfusion saved with this technique and to report the use of 3.5070 polygeline (haemaccel) as the diluent which has not previously been reported.
MATERIAL AND METHODS

Patients
Fifty-seven patients undergoing elective major vascular surgery were included in this prospective study. Thirty-two were haemodiluted and compared with 25 patients in whom the technique was contra-indicated because of pre-existing anaemia, significant cardiac disease, or severe respiratory disease or a combination of these conditions. Haemodiluted patients compensate for the fall in haemoglobin content by a rise in cardiac output, so that provided the haemoglobin is fully saturated with oxygen, by maintaining an arterial oxygen tension over 100 mmHg, the oxygen carrying capacity of the blood is maintained within normal limits. Patients with pre-existing anaemia will not benefit from further haemodilution, patients with severe respiratory disease may not be able to maintain an arterial oxygen tension over 100 mmHg in the peri-operative period and patients with severe heart disease may not be able to increase their cardiac output. The age, sex, preoperative haemoglobin concentration, and type of operation of both groups of patients is shown in Table 1 . Two patients in the nonhaemodiluted group had renal insufficiency and one had been on aspirin; however, none had evidence of a coagulopathy. Though the patients were not randomised it was considered that because they were having similar operations, the intra-operative blood loss and pattern of blood replacement could be compared, but no comparison of morbidity or mortality could be made.
Anaesthesia
The aim of the anaesthetic technique was to use agents which would be least likely to prevent the increase in cardiac output which must occur when the patient is haemodiluted. We used a relaxant, opiate, nitrous oxide technique which was occasionally supplemented with halothane.
Monitoring
Clinical monitoring was supplemented with electrocardiographic monitoring for myocardial ischaemia using the chest lead V5. Blood pressure was measured continuously via a radial artery cannula, though this was interrupted during the process of blood collection. Central venous pressure was measured intermittantly as was the urine output. Arterial haematocrit was measured frequently throughout the operation by a centrifuge located in the anaesthetic induction room as it was considered important to make this measurement before deciding on the nature of the fluids selected for blood volume replacement. The haematocrit was used as it is an easy measurement to carry out in the operating room and can be converted to approximate haemoglobin concentration by dividing the haematocrit by 3, provided the red cells have a normal mean corpuscular haemoglobin content. Blood loss was estimated by weighing surgical packs, measuring the volume of blood in the suction bottles, and estimating the blood loss on the surgical drapes. Blood gases were measured to ensure that the arterial oxygen tension was greater than 100 mmHg.
Technique oJ haemodilution and autotransJusion
After the induction of anaesthesia, while the patient was being draped and the abdominal incision made, 29 patients had 850 ml of autologous blood (2 units) collected in standard disposable blood collecting bags each containing 75 ml of the anticoagulant acidcitrate-dextrose, and three patients had 1275 ml of autologous blood collected (3 units) . This blood volume was replaced simultaneously with 3.5070 polygeline 500 ml per unit of blood Anaesthesia and In{ensil'c Care, Vo/. X, l',,'o, 3, August, 1982 collected. The blood was collected through the radial artery cannula (20G Medicut) from a three-way stopcock placed between the cannula and the manometer line leading to the transducer for recording blood pressure. This site was chosen to ensure the smallest possible exposure to plastic of the platelets in the autologous blood. A 20G Medicut was chosen as this allowed collection of blood at a reasonable rate of about 1 unit of blood per 10 minutes. The pack containing the autologous blood was continuously weighed during collection so that the volume collected could be replaced at the same rate with 3.5070 polygeline. The autologous blood was clearly marked to indicate the order of collection and stored at room temperature.
Blood loss during surgery was immediately replaced with equal volumes of 3.5% polygeline or homologous blood, depending on the haematocrit level. Homologous blood was given if the haematocrit fell below 0.30 and polygeline if it was above this level. The maintenance of normal blood volume was confirmed by continual reassessment of cardiovascular parameters. Re-infusion of the autologous blood was begun when the vascular anastomoses were complete and haemostasis secured. The units were re-transfused in the reverse order of collection via a short plastic giving set (Tuta Add-a-line)* which did not have a filter, so as to ensure maximum retransfusion of the platelets in the autologous blood.
Postoperative care
Postoperatively all the patients were left intubated and ventilated for 12-24 hours in the intensive care ward. Further blood volume replacement requirements were assessed clinically and replacement was with colloid or blood, according to haematocrit measurements. If the haematocrit was less than 0.30 homologous blood was given, but if it was greater than 0.30 either polygeline or stable plasma protein solution (SPPS) was administered. The patients were then followed until their discharge from hospital. All complications and additional blood transfusion requirements were noted. Anaemic patients were given oral iron for approximately one month after their operation. 
Non-diluted patients
These patients were given similar anaesthetics and monitored in the same way during the operation as described for the haemodiluted patients. Blood loss during surgery was replaced with one litre of polygeline and then homologous blood in the non-anaemic patients. The anaemic patients (five patients) had blood loss replaced with homologous blood and polygeline, to maintain their haematocrits at pre-operative levels. Postoperatively further blood volume requirements were replaced with homologous blood or colloid in order to maintain their haematocrit greater than 0.35 (except anaemic patients).
Statistical methods
All data was analysed using Student's t-test and p levels less than 0.05 were taken to be significant. Table 2 . The mean intra-operative blood loss was similar in both groups of patients but the homologous blood transfusion requirements were significantly different. The blood volume replacement given in the first 24 hours post operatively is shown in Table 3 . Once again the homologous blood requirements are statistically significantly different. In the subsequent postoperative course, five of the haemodiluted patients were given more homologous blood because their haematocrits fell below 0.30, whereas none of the non-diluted group received more homologous blood. Table 4 compares the number of units of homologous blood required in each group of patients; this shows a statistically significant difference between the two groups. None of the haemodiluted patients required fresh frozen plasma or platelets but in the non-diluted group, four patients received fresh frozen plasma and one received platelets as it was considered that homologous blood transfusion requirements were in excess of 10 units, which in our intensive care unit is taken as an indication for fresh frozen plasma or platelets.
RESULTS
Intra-operative blood loss and blood volume replacement is shown in
The mean haematocrit changes in the haemodiluted patients are shown in Table 5 .
There were no deaths in the haemodiluted patients. Postoperative respiratory infections occurred in 13 patients, three patients Units of hOlllologous blood required (lIIean and standard del'iation). developed minor wound infections and one patient had a small skin slough in a groin wound. Two patients had more complicated postoperative courses. One developed myocardial ischaemia, septicaemia and atrial fibrillation but recovered even though haemodilution was maintained, and one patient developed renal insufficiency from which he recovered. No patient was re-operated upon for bleeding. Three deaths occurred in the nondiluted patients, two from renal failure and one from septicaemia. Respiratory infections occurred in eight patients, two developed wound infections and one patient required secondary suture of a groin wound. Myocardial infarction occurred in two patients, three developed renal insufficiency and four had transient jaundice. There were again no patients operated upon for postoperative bleeding. However, the morbidity and mortality of the two groups can not be compared as the two groups were not randomised.
DISCUSSION
Intra-operative haemodilution and autotransfusion is applicable to patients having elective surgery in which blood loss is anticipated to be in the order of 2000 ml. 3 It has been used in cardiac surgery, 4-6 vascular surgerY,7.8 major orthopaedic surgery, 9 gynaecological surgery, 10 and maj or general surgery. 11 In all cases saving of homologous blood transfusion has been reported varying from 18070 to 90070. This reduces the risks of homologous blood transfusion to the patient and may have specific advantages in patients having vascular surgery by decreasing blood viscosity and increasing graft blood flow. Le Veen et al. 12 showed that in haemodiluted dogs
femoral artery graft patency was significantly better than those in non-haemodiluted dogs. Their impression was that this also applied to patients undergoing vascular reconstruction.
Yates et al. 13 have shown that normovolaemic haemodilution increases calf blood flow in patients with intermittent claudication due to peripheral vascular disease. This increase may be an important adjunct to ensure early patency of vascular reconstructions.
The benefits of haemodilution and autotransfusion must be weighed against the potential risk of hypoxia due to excessive haemodilution or hypovolaemia. It is generally accepted that patients who do not have serious cardiac or respiratory disease will maintain their oxygen carrying capacity by an increase in cardiac output,3,7 provided the haematocrit is kept above 0.25 14 and the arterial oxygen tension above 100 mmHg. We feel that a haematocrit of 0.25 should be the lower limit during the operation and that 0.30 is a safer limit when the patient leaves the well-controlled conditions of the operating theatre. Hypovolaemia should be prevented by the continuous assessment of blood loss, and matching this with blood volume replacement to maintain normal cardiovascular parameters.
A number of different diluents have been used for haemodilution. They include Ringer's lactate,IO 5OJo albumen,11 dextran 60,15 dextran 70,3 or combinations of agents such as 5OJo albumen and normal saline,7 4% albumen and Ringer's lactate,9 dextran 40 and balanced salt solution,S dextran 60 and 5% albumen ls and hydroxethyl starch and 5% albumen. 15 Polygeline (haemaccel) has not however been reported for this purpose and yet it has some desirable properties when used for haemodilution. Its relatively short half-life of four hours l6 is ideal for haemodilution because it is important to maintain normovolaemia throughout the operation and yet at the end there are two units of autologous blood to reinfuse. This infusion could result in hypervolaemia unless the diluent was being excreted, as occurs with polygeline. SPPS is an alternative but it is expensive,17 and if used would not satisfy one of the aims of haemodilution, which is to conserve homologous blood and blood products. Dextran 70 is another suitable agent but these Anaesthesia and Inlensive Care, Vol. X, No. 3, August, 1982 patients required about three litres of the diluent in 24 hours and this would exceed the dose of 1.5 g of dextran 70 per kilogram of body weight, which the manufacturers state is associated with bleeding diatheses. IS Our study shows that intra-operative haemodilution and autotransfusion does reduce homologous blood transfusion requirements and that polyge1ine is a suitable diluent. Wound healing was adequate and wound infection rate acceptably low, again adding additional support to the view that high haemoglobin levels are unnecessary to promote wound healing, hasten convalescence and prevent infection. I Respiratory infection in haemodiluted patients should be treated energetically, and supplemental oxygen administered to avoid postoperative hypoxia.
